keyword
https://read.qxmd.com/read/38627835/treatment-outcomes-in-patients-with-acute-thromboembolic-occlusion-of-the-superior-mesenteric-artery
#41
JOURNAL ARTICLE
Wenrui Li, Mingyuan Liu, Lei Jin, Hai Feng, Xueming Chen, Zhiwen Zhang
OBJECTIVES: The goals of this study were to investigate the treatment outcomes of acute thromboembolic occlusion of the superior mesenteric artery (ATOS) and identify prognostic factors after treatment. METHODS: The clinical data of 62 patients with ATOS between 2013 and 2021 were retrospectively reviewed. Patients were stratified by the treatment strategy, complications and mortality were compared in different group. RESULTS: Sixty-two consecutive patients were identified with ATOS...
April 16, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38627137/association-of-preoperative-beta-blocker-use-and-cardiac-complications-after-major-noncardiac-surgery-a-prospective-cohort-study
#42
JOURNAL ARTICLE
Noemi Glarner, Christian Puelacher, Danielle M Gualandro, Mirjam Pargger, Gabrielle Huré, Silvia Maiorano, Ivo Strebel, Simona Fried, Daniel Bolliger, Luzius A Steiner, Andreas Lampart, Giovanna Lurati Buse, Edin Mujagic, Didier Lardinois, Christoph Kindler, Lorenz Guerke, Stefan Schaeren, Andreas Mueller, Martin Clauss, Andreas Buser, Angelika Hammerer-Lercher, Christian Mueller
INTRODUCTION: Cardiac complications after major noncardiac surgery are common and associated with high morbidity and mortality. How preoperative use of beta-blockers may impact perioperative cardiac complications remains unclear. METHODS: In a multicentre prospective cohort study, preoperative beta-blocker use was ascertained in consecutive patients at elevated cardiovascular risk undergoing major noncardiac surgery. Cardiac complications were prospectively monitored and centrally adjudicated by two independent experts...
April 15, 2024: British Journal of Anaesthesia
https://read.qxmd.com/read/38623472/ticagrelor-vs-clopidogrel-when-coadministered-with-bivalirudin-in-patients-with-acute-coronary-syndrome-undergoing-percutaneous-coronary-intervention
#43
JOURNAL ARTICLE
Yang Li, Yi Li, Miaohan Qiu, Yu Xue, Kai Xu, Yaling Han
BACKGROUND: The optimal perioperative antithrombotic strategy for patients with acute coronary syndrome (ACS) during percutaneous coronary intervention (PCI) remains controversial. OBJECTIVES: To determine the safety and effectiveness of bivalirudin plus ticagrelor vs bivalirudin plus clopidogrel in patients with ACS undergoing PCI in the real world. METHODS: Between March 2016 and March 2019, 7234 patients with ACS who had undergone PCI, received bivalirudin periprocedurally, and were prescribed ticagrelor or clopidogrel were enrolled in a single-center, all-comer, modern, retrospective cohort study...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38621942/-gualou-xiebai-banxia-decoction-treats-type-2-diabetes-mellitus-combined-with-acute-myocardial-infarction-via-chemerin-cmklr1-ppar%C3%AE-signaling-pathway
#44
JOURNAL ARTICLE
Lei Wang, Shuai Guan, Meng-Xue Wu, Hui Zhou, Qi-Tao Zhao, Li-Ying Xun
This study aims to investigate the effects of Gualou Xiebai Banxia Decoction(GXBD) on type 2 diabetes mellitus(T2DM) combined with acute myocardial infarction(AMI) in rats via chemerin/chemokine-like receptor 1(CMKLR1)/peroxisome proliferator-activated receptor α(PPARα) signaling pathway, and to explore the mechanism of GXBD in alleviating glucose and lipid metabolism disorders. The SD rats were randomized into control, model, positive control, and low-and high-dose GXBD groups. The rat model of T2DM was established by administration with high-fat emulsion(HFE) by gavage and intraperitoneal injection with streptozotocin, and then coronary artery ligation was performed to induce AMI...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621711/feasibility-and-safety-of-bridging-antiplatelet-therapy-with-cangrelor-in-neuro-oncology-a-preliminary-experience
#45
JOURNAL ARTICLE
Giacomo Bertolini, Laura Belli, Stefania Mazza, Pietro Tito Ugolotti, Iacopo Tadonio, Patrizia Ceccarelli, Sandra Rossi, Salvatore Ippolito
Antiplatelet therapy is mandatory for prevention of thrombotic events in patients with a recent history of acute coronary syndromes and/or percutaneous coronary interventions. However, if an urgent surgery is required during antiplatelet therapy, a compromise between the ischemic/thrombotic and hemorrhagic risk has to be reached. Different bridging schemes are reported in the literature, but there is no clear consensus on the optimal treatment strategy in terms of efficacy and safety. Although some indications about the perioperative management of antiplatelet therapy regarding specific surgical specializations are available, balancing the thrombotic and hemorrhagic risk on an individual basis, no evidence referring to neurosurgical or neuro-oncologic procedures is reported...
April 15, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38619775/risk-of-cardiovascular-events-in-schizophrenic-patients-treated-with-paliperidone-palmitate-once-monthly-injection-pp1m-a-population-based-retrospective-cohort-study-in-taiwan
#46
JOURNAL ARTICLE
Shih-Pei Shen, Li Yan, Tao Wu, Min-Wei Huang, Kuan-Chih Huang, Hong Qiu, Yongjing Zhang, Chao-Hsiun Tang
BACKGROUND: Schizophrenia is one of the leading causes of disability. Paliperidone palmitate once-monthly injection (PP1M) was developed to provide consistent drug delivery and improve medication adherence for maintenance treatment. It is well known that patients with schizophrenia have higher cardiovascular risks, however little is known about the cardiovascular risks of patients with schizophrenia treated with PP1M in Asia. OBJECTIVE: This study aimed to estimate the incidence of cardiovascular events after initiating PP1M treatment and evaluate the cardiovascular risk associations compared with oral second-generation antipsychotics (SGAs)...
April 15, 2024: Clinical Drug Investigation
https://read.qxmd.com/read/38619649/ticagrelor-versus-clopidogrel-in-acute-large-vessel-ischemic-stroke-a-randomized-controlled-single-blinded-trial
#47
JOURNAL ARTICLE
Mohamed G Zeinhom, Ahmed Elbassiouny, Ahmed Mahmoud Mohamed, Sherihan Rezk Ahmed
BACKGROUND: Large-vessel ischemic stroke represents about 25-40% of all ischemic strokes. Few clinical trials compared ticagrelor versus clopidogrel in ischemic stroke patients; all these studies included only patients with a transient ischemic attack or minor stroke; moreover, none of these studies included patients from North Africa. OBJECTIVES: We aimed to compare ticagrelor versus clopidogrel in the first-ever large-vessel occlusion (LVO) acute ischemic stroke in Egypt...
April 15, 2024: CNS Drugs
https://read.qxmd.com/read/38617797/carbon-dots-derived-from-curcumae-radix-and-their-heartprotective-effect
#48
JOURNAL ARTICLE
Liyang Dong, Yafang Zhao, Juan Luo, Xiaopeng Li, Shuxian Wang, Menghan Li, Peng Zou, Hui Kong, Qingguo Wang, Yan Zhao, Huihua Qu
BACKGROUND: Acute myocardial infarction (AMI) is a common cardiovascular disease in clinic. Currently, there is no specific treatment for AMI. Carbon dots (CDs) have been reported to show excellent biological activities, which hold promise for the development of novel nanomedicines for the treatment of cardiovascular diseases. METHODS: In this study, we firstly prepared CDs from the natural herb Curcumae Radix Carbonisata (CRC-CDs) by a green, simple calcination method...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38617635/plasma-metabolic-profiling-and-multiclass-diagnostic-model-development-for-stable-angina-pectoris-and-acute-myocardial-infarction
#49
JOURNAL ARTICLE
Ruixia Lu, Wenyong Lin, Qipeng Jin, Dongyuan Wang, Chunling Zhang, Huiying Wang, Tiejun Chen, Junjie Gao, Xiaolong Wang
Coronary heart disease remains a major global health challenge, with a clear need for enhanced early risk assessment. This study aimed to elucidate metabolic signatures across various stages of coronary heart disease and develop an effective multiclass diagnostic model. Using metabolomic approaches, gas chromatography-mass and liquid chromatography-tandem mass spectrometry were used to analyze plasma samples from healthy controls, patients with stable angina pectoris, and those with acute myocardial infarction...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38617591/pulmonary-embolism-with-paradoxical-embolization-to-right-coronary-artery-in-the-presence-of-a-large-patent-foramen-ovale-a-case-report
#50
Erik Boberg, Anders Hedman, Jacob Hollenberg
BACKGROUND: Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most frequent cause of cardiovascular death. The clinical presentation of PE is variable, and choosing the appropriate treatment for individual patients can be challenging. CASE SUMMARY: A 64-year-old man presented to hospital with acute chest pain, shortness of breath, and pulmonary oedema. Electrocardiogram revealed ST-elevation myocardial infarction. D-dimer was 18.8 mg/L fibrinogen equivalent units (FEU) (normal <0...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38617067/concurrent-myocardial-infarction-in-the-setting-of-thrombotic-thrombocytopenic-purpura-secondary-to-systemic-lupus-erythematosus-a-case-report
#51
Saleh Azadbakht, Bardia Amidi, Narges Naderi, Anwar Sharifaskari, Mahtab Hatami
KEY CLINICAL MESSAGE: In acute thrombotic thrombocytopenic purpura (TTP), apart from urgent treatment, assessing the patient's medical history, especially conditions like systemic lupus erythematosus that could trigger TTP, is crucial. Rarely, TTP patients may experience cardiac conditions as severe as a myocardial infarction. ABSTRACT: A 45-year-old woman manifested severe and acute thrombotic thrombocytopenic purpura (TTP) of unknown origin. The patient's symptoms, the laboratory data, the detection of the reduction in ADAMTS13 activity, and the presence of schistocytes on the peripheral smear confirmed the diagnosis...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38613636/circdiaph3-aggravates-h-r-induced-cardiomyocyte-apoptosis-and-inflammation-through-mir-338-3p-srsf1-axis
#52
JOURNAL ARTICLE
Lin Lin, Li Wang, Aimin Li, Yanzhuo Li, Xiaolong Gu
Acute myocardial infarction (AMI) is one of the most prevalent cardiovascular diseases, accounting for a high incidence rate and high mortality worldwide. Hypoxia/reoxygenation (H/R)-induced myocardial cell injury is the main cause of AMI. Several studies have shown that circular RNA contributes significantly to the pathogenesis of AMI. Here, we established an AMI mouse model to investigate the effect of circDiaph3 in cardiac function and explore the functional role of circDiaph3 in H/R-induced cardiomyocyte injury and its molecular mechanism...
April 13, 2024: Journal of Bioenergetics and Biomembranes
https://read.qxmd.com/read/38609970/left-ventricular-free-wall-rupture-caused-by-myocardial-ischemia-without-treatable-atherosclerotic-coronary-disease-a-case-series
#53
JOURNAL ARTICLE
Terézia B Andrási, Nunijiati Abudureheman, Alannah C Glück, Kai Dielmann, Gerhard Dinges
BACKGROUND: The clinical presentation of left ventricular free wall rupture (LVFWR) varies ranging from uneventful condition to congestive heart failure. Here we report two cases of LVFWR with different clinical presentation and notable outcome. A 53-year-old male presenting emergently with signs of myocardial infarction received immediate coronary angiography and thoracic CT-scan showing occlusion of the first marginal coronary branch without possibility of revascularization and minimal pericardial extravasation...
April 12, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38608997/rationale-and-design-for-the-randomized-placebo-controlled-double-blind-trial-studying-the-effect-of-single-antiplatelet-therapy-clopidogrel-versus-dual-antiplatelet-therapy-clopidogrel-acetylsalicylic-acid-on-the-occurrence-of-atherothrombotic-events-following
#54
JOURNAL ARTICLE
Emilien C J Wegerif, Çağdaş Ünlü, Manon I Generaal, Rutger van den Bor, Peter M van de Ven, Michiel L Bots, Gert J de Borst
RATIONALE: Antiplatelet therapy (APT) is the standard of care after endovascular revascularization (EVR) in patients with peripheral artery disease (PAD). APT aims to prevent both major adverse cardiovascular events (MACE) and major adverse limb events (MALE). Nonetheless, the rates of MACE and MALE after EVR remain high. In coronary artery and cerebrovascular disease, dual APT (DAPT)compared to acetylsalicylic acid alone has proven to reduce MACE without increasing the risk of major bleeding when applied for a restricted number of weeks...
April 10, 2024: American Heart Journal
https://read.qxmd.com/read/38607606/safety-and-outcomes-of-surgical-treatment-of-atrial-fibrillation-in-emergency-surgery-cases
#55
JOURNAL ARTICLE
Shun-Ichiro Sakamoto, Tomohiro Murata, Motohiro Maeda, Atsushi Hiromoto, Takako Yamaguchi, Kenji Suzuki, Yosuke Ishii
BACKGROUND: Recent developments in surgical devices, including left atrial appendage closure, have enabled surgeons to perform aggressive operations for atrial fibrillation (AF). However, the outcomes of AF surgery in emergent cases have not been extensively studied. OBJECTIVE AND METHODS: The present study aimed to investigate the effectiveness of AF surgery in emergency surgery cases associated with cardiovascular events. We enrolled 18 patients who underwent various types of AF surgery due to emergencies, including acute aortic dissection (n = 6), acute myocardial infarction (n = 5), bleeding due to perforation from radiofrequency catheter ablation (n = 4), acute mitral regurgitation (n = 2), and cardiac tumor (n = 1)...
April 12, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38606380/acute-myocardial-infarction-complicated-by-cardiogenic-shock-in-ukraine-multicentre-registry-analysis-2021-2022
#56
JOURNAL ARTICLE
Anton O Bilchenko, Olga V Gritsenko, Volodymir O Kolisnyk, Oleg I Rafalyuk, Andrii V Pyzhevskii, Yaroslav V Myzak, Dmytro I Besh, Victor M Salo, Sergii O Chaichuk, Mykhailo O Lehoida, Ihor V Danylchuk, Ihor V Polivenok
BACKGROUND: Data on the results and management strategies in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) in the Low and Lower-Middle Income Countries (LLMICs) are limited. This lack of understanding of the situation partially hinders the development of effective cardiogenic shock treatment programs in this part of the world. MATERIALS AND METHODS: The Ukrainian Multicentre Cardiogenic Shock Registry was analyzed, covering patient data from 2021 to 2022 in 6 major Ukrainian reperfusion centres from different parts of the country...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38606373/engineered-exosomes-with-growth-differentiation-factor-15-overexpression-enhance-cardiac-repair-after-myocardial-injury
#57
JOURNAL ARTICLE
Ailin Zou, Tingting Xiao, Boyu Chi, Yu Wang, Lipeng Mao, Dabei Cai, Qingqing Gu, Qianwen Chen, Qingjie Wang, Yuan Ji, Ling Sun
BACKGROUND: Cardiac repair remains a thorny issue for survivors of acute myocardial infarction (AMI), due to the regenerative inertia of myocardial cells. Cell-free therapies, such as exosome transplantation, have become a potential strategy for myocardial injury. The aim of this study was to investigate the role of engineered exosomes in overexpressing Growth Differentiation Factor-15 (GDF-15) (GDF15-EVs) after myocardial injury, and their molecular mechanisms in cardiac repair. METHODS: H9C2 cells were transfected with GDF-15 lentivirus or negative control...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38605443/circbcl2l13-attenuates-cardiomyocyte-oxidative-stress-and-apoptosis-in-cardiac-ischemia%C3%A2-reperfusion-injury-via-mir-1246-peg3-signaling
#58
JOURNAL ARTICLE
Hua Wu, Hairui Li, Qian Zhang, Jia Song, Yongbin Chen, Ze-Mu Wang, Weipeng Jiang
Ischemia‒reperfusion (I/R) is a common complication in the clinical treatment of acute myocardial infarction (MI), in which cardiomyocytes play a pivotal role in the recovery of cardiac function after reperfusion injury. The expression of numerous circular ribonucleic acids (circRNAs) is disrupted in I/R-induced cardiac damage, but the potential role of circRNAs in I/R damage has not been fully elucidated. The purpose of the present study was to clarify the biological action and molecular mechanism of circRNA 002166 (also termed circCL2L13) in postmyocardial I/R...
April 2024: Journal of Biochemical and Molecular Toxicology
https://read.qxmd.com/read/38604450/high-dose-statin-treatment-reduces-circulating-dickkopf-1-following-acute-myocardial-infarction
#59
JOURNAL ARTICLE
Thor Ueland, Noreen Butt, Tove Lekva, Stein Ørn, Cord Manhenke, Pål Aukrust, Alf Inge Larsen
BACKGROUND: Secreted glycoproteins of the Dickkopf (DKK) family modify Wnt signaling and may influence plaque destabilization but their modulation by statins in MI patients is not known. METHODS: We measured plasma DKK-1 and DKK-3 in patients with acute ST-segment elevation MI (STEMI) before percutaneous coronary intervention (PCI) and after 2 and 7 days and 2 months in patients receiving short-term high-dose (40 mg rosuvastatin, given before PCI; n = 25) and moderate dose (20 mg simvastatin, given the day after PCI; n = 34)...
April 9, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38604385/cardiac-delivery-of-modified-mrna-using-lipid-nanoparticles-cellular-targets-and-biodistribution-after-intramyocardial-administration
#60
JOURNAL ARTICLE
M C I Labonia, M Estapé Senti, P H van der Kraak, M A D Brans, I Dokter, T J Streef, A M Smits, A K Deshantri, S C A de Jager, R M Schiffelers, J P G Sluijter, P Vader
Despite research efforts being made towards preserving (or even regenerating) heart tissue after an ischemic event, there is a lack of resources in current clinical treatment modalities for patients with acute myocardial infarction that specifically address cardiac tissue impairment. Modified messenger RNA (modRNA) presents compelling properties that could allow new therapeutic strategies to tackle the underlying molecular pathways that ultimately lead to development of chronic heart failure. However, clinical application of modRNA for the heart is challenged by the lack of effective and safe delivery systems...
April 9, 2024: Journal of Controlled Release
keyword
keyword
75868
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.